Oxolamine citrate

CAS No. 1949-20-8

Oxolamine citrate( Oxalamine Citrate | Oxalamine Citrate salt )

Catalog No. M13049 CAS No. 1949-20-8

Oxolamine is a cough suppressant that is available as a generic drug in many jurisdictions.

Oxolamine is a cough suppressant that is available as a generic drug in many jurisdictions.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
200MG 28 In Stock
500MG 38 In Stock
1G 45 In Stock

Biological Information

  • Product Name
    Oxolamine citrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Oxolamine is a cough suppressant that is available as a generic drug in many jurisdictions.
  • Description
    Oxolamine is a cough suppressant that is available as a generic drug in many jurisdictions.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Oxalamine Citrate | Oxalamine Citrate salt
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    1949-20-8
  • Formula Weight
    437.44
  • Molecular Formula
    C14H19N3O·C6H8O7
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 10 mM
  • SMILES
    CCN(CC)CCC1=NC(C2=CC=CC=C2)=NO1.OC(C(O)=O)(CC(O)=O)CC(O)=O
  • Chemical Name
    N,N-Diethyl-2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethanamine citrate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ceyhan BB, Karakurt S. Respir Med. 2002 Jan;96(1):61-3.
molnova catalog
related products
  • Itaconic anhydride

    Itaconic anhydride

  • Gastrin-Releasing Pe...

    Gastrin-releasing peptide is a regulatory human peptide that elicits gastrin release and regulates gastric acid secretion and enteric motor function. The post-ganglionic fibers of the vagus nerve that innervate the G cells of the stomach release GRP, which stimulates the G cells to release gastrin.

  • Malonic acid

    Malonic acid (propanedioic acid) is the archetypal example of a competitive inhibitor: it acts against succinate dehydrogenase (complex II) in the respiratory electron transport chain. Malonic acid is found to be associated with malonyl-CoA decarboxylase deficiency which is an inborn error of metabolism.